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ABSTRACT
Ribonucleotide reductase catalyzes a rate-limiting
reaction in DNA synthesis by converting ribonucleo-
tides to deoxyribonucleotides. It consists of two sub-
units and the smallone, M2 (orR2),plays anessential
role in regulating the enzyme activity and its expres-
sionisfinelycontrolled.ChangesintheM2levelinflu-
encethedNTPpooland,thus,DNAsynthesisandcell
proliferation. M2 gene has two promoters which pro-
duce two major mRNAs with 50-untranslated regions
(50-UTRs) of different lengths. In this study, we found
that the M2 mRNAs with the short (63 nt) 50-UTR can
betranslatedwithhighefficiencywhereasthemRNAs
with the long (222 nt) one cannot. Examination of the
long50-UTRrevealedfourupstreamAUGs,whicharein
the same reading frame as the unique physiological
translation initiation codon. Further analysis demon-
strated that these upstream AUGs act as negative cis
elements for initiation at the downstream translation
initiationcodonandtheirinhibitoryeffectonM2trans-
lation is eIF4G dependent. Based on the findings of
this study, we conclude that the expression of M2 is
likelyregulatedbyfinetuningthetranslationfromthe
mRNA with a long 50-UTR during viral infection and
during the DNA replicationphase of cell proliferation.
INTRODUCTION
Ribonucleotide reductase (RR) is an enzyme that catalyzes
the reaction converting ribonucleotides to their corresponding
deoxyribonucleotides, the precursor of DNA synthesis and
DNA repair. This reaction is a rate-limiting step of the syn-
thesis of dNTP and, thus, of DNA (1). Because DNA synthesis
is an essential event of cell cycle progression, down-regulating
the level or decreasing the activity of RR also reduces the
dNTP pool, and consequently decreases the DNA synthesis
which in turn results in reduced cell growth (2,3).
Mammalian RR consists of two different subunits, M1 and
M2 (or R1 and R2), which are both required for the RR activ-
ity. The expression levels of these two subunits are regulated
differently during cell cycle progression. While the level of
M1 appears to be constant throughout the cell cycle in pro-
liferating cells (4,5), the level of M2 oscillates with cell cycle
and peaks in S-phase (6,7). Thus, the level of the M2 subunit
plays an essential role in regulating the active RR and, there-
fore, DNA synthesis and cell proliferation (6).
It has been found previously that over-expression of M2
increased the malignancy of H-ras transformed ﬁbroblasts and
enhanced the invasive potential of human cancer cells (8,9).
Several anti-proliferation agents, such as hydroquinone, orotic
acid and hydroxyurea, were reported to inhibit DNA synthesis
byinhibitingtheexpressionoractivityofM2andconsequently
reducing the dNTP pool (10–13). Down regulating the level of
M2 with antisense oligonucleotides or DNA speciﬁc to M2
has been shown to cause the decrease in RR activity, cell
proliferation, tumorigenecity and metastasis of a variety of
human cancer cells (14,15). Clearly, the activity or the expres-
sion level of M2 subunit is closely related to the proliferation
of cells and may be a malignancy determinant critically
involved in mechanisms controlling malignancy progression.
Thus, delineating the regulatory mechanism of M2 expression
is very important for understanding the control of cell prolif-
eration and cancer and for designing better cancer therapeutics
by targeting M2.
The regulation of M2 expression occurs at both transcrip-
tional and post-transcriptional levels. It has been reported that
the mRNA level of M2 oscillates with cell cycle with being
undetectable in G0/G1,rising at the G1-S border and peaking in
S phase, and ﬁnally declining in G2-M (16–18). The promoter
activityofM2couldbeinducedupto10-foldbyUVirradiation
inadose-dependent manner(19).However,ingrowth-arrested
Caski cells treated with ionizing radiation, the protein level of
M2 increased 17-fold without any change in the mRNA level
(20),suggestingthat theM2expressionisalsocontrolledatthe
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synthesis of M2 is decreased without any change in its mRNA
level by mimosine, a plant non-protein amino acid, and that
the eIF3 p170 may be a mediator of the mimosine effect
(21,22).
It has been reported that the M2 gene has two promoters
responsible for the production of two major transcripts with
50-untranslated regions (50-UTRs) of 63 and 222 nt, respect-
ively (23,24), and it is unknown whether both mRNA species
can be translated and how their translations are regulated.
In this study, we investigated the translational regulation of
these two M2 mRNA species. We found that the long 50-UTR
contains four AUGs that are in the same reading frame as the
physiological translation initiation codon and these AUGs
are not used as translation initiation sites to generate M2
with an extended N-terminus but instead they act as negative
cis-regulatory elements for translation at the physiological
initiation codon.
MATERIALS AND METHODS
Materials
Monoclonal antibody YL1/2 against RR M2 was purchased
from Accurate Chemical & Scientiﬁc Corp. (Westbury, NY).
Plasmid pCMV2A is a kind gift from Dr Robert G. Korneluk
(Apoptogen Inc, Ottawa, Ontario, Canada). Mimosine and
monoclonal antibody against b-actin were purchased from
Sigma (St Louis, MO). Soluble Trail and the luciferase
assay system were purchased from BioMol Research Labs
(Plymouth Meeting, PA) and Promega (Madison, WI) respect-
ively. The enhanced chemiluminescence and [
35S]methionine
were from Amersham (Arlington Heights, IL) and PerkinEl-
mer (Boston, MA) respectively. The Sequi-Blot
TM PVDF
membrane and concentrated protein assay dye reagent were
from BioRad (Hercules, CA). pCRM2 containing M2 cDNA
was purchased from ATCC (Manassas, VA) and cell culture
media and reagents, vector pcDNA3 were obtained from Invit-
rogen (Carlsbad, CA). All other reagents were of molecular
biology grade and purchased from Sigma (St Louis, MO) or
Fisher Scientiﬁc (Chicago, IL).
Anti M2 antibody preparation
The polyclonal antibodies against human M2, antiSM2 and
antiLM2, were generated commercially by Alpha Diagnostic
International Company (San Antonio, TX). Brieﬂy, peptides
with the N-terminal sequence of the putative long form of M2
(MGRVGGMAQPMGRAG) and an internal sequence of the
short M2 (TDPQQLQLSPLKGLSLVDKE) were synthesized
chemically and conjugated to KLH. Rabbits were immunized
with these conjugated peptides and sera were prepared and
characterized against the peptides by ELISA.
Engineering of the M2 constructs
M2 has two major mRNA species with different lengths of
50-UTRs. The long and short 50-UTRs of M2 gene were cloned
by PCR using genomic DNA as templates and the follow-
ing primers: 50-GCGCCTCGAGCGCGCGCCCGCGGCCA-30
(long50-UTR,forward);50-GCGCCTCGAGCCCGTGCACC-
CTGTCCCA-30 (short 50-UTR, forward); and 50-CGTGTTC-
TCCTTGTCGACCAAGCTGA-30 (reverse). The M2 cDNA
constructs containing the different lengths of 50-UTRs,
pCRLM2 and pCRSM2, were generated by inserting the
long and short 50-UTRs into the sites of SalI and XhoI of
pCRM2, respectively.
The reporter constructs were generated by subcloning the
luciferase gene from pGL3 (Promega) directly into the EcoRI
and BamHI sites of PCRII (Invitrogen) to create pCRL. The
50-UTRs of M2 gene and the poly(A) tail from pSP64-Poly(A)
vector (Promega) were released and cloned into the NcoI/XhoI
and BamHI/HindIII sites of pCRL, respectively, resulting in
the constructs pCRL-Luc-A30 and pCRS-Luc-A30 that con-
tain the long and short M2 50-UTRs, respectively. In these
constructs, the luciferase gene with 50-UTRs of M2 was under
the control of T7 promoter and there is a poly(A) sequence at
the 30 end of the coding sequence.
The mutants of reporter constructs were engineered using
PCR as described previously (25). The primers used for dele-
tion mutations are as follows: LM2D1: 50-CGCTCGAGGG-
AAGGGTCGGAGGCAUGGCA-30; LM2D2: 50-CGCTCGA-
GCAGCCAAUGGGAAGGGCCGGGGCACCA-30; LM2D3:
50-CGCTCGAGAGGGCCGGGGCACCAAAGCCA-30;
LM2D4:50-GCCGCTCGAGGGAAGGGCCGGGAGCGCG-30;
LM2D5: 50-GCCGCCGAGAAAGGCTGCTGGAGTGAGG-
GGT-30;andLM2D6:50-GCCGCTCGAGAGTGAGGGGTC-
GCCCGTGCACCCT-30.Theprimersusedforpointmutations
are as follows: 50-CAGCCATTCGGAAGGGTCGGAGGCA-
UGGCA-30 (forward, uAUG1); 50-TCCGAAUGGCTGCGC-
CTTGCCCCTACC-30 (reverse, uAUG1); 50-GTCGGAGGC-
TTCGCACAGCCAAUG-30 (forward, uAUG2); 50-TGGC-
TGTGCGAAGCCTCCGACCCTTCC-30 (reverse, uAUG2);
50-CCATTCGGAAGGGCCGGGGCACCAAAG-30 (forward,
uAUG3); 50-CCTTCCGAAUGGCTGTGCGAAGCCTCCCT-30
(reverse,uAUG3);50-TTCGGAAGGGCCGGGAGCGCGCG-
GCGC-30; (forward, uAUG4); and 50-GGCCCTTCCGAAU-
GGCTTTGGTGCCCCG-30 (reverse, uAUG4). All constructs
were conﬁrmed by DNA sequencing.
Cell lines, treatment and transfection
HeLa cells were maintained in modiﬁed Eagle’s medium sup-
plemented with 10% fetal bovine serum and in humidiﬁed
atmosphere of 5% CO2 at 37 C. HeLa cells were seeded at
6 · 10
5 cells in 100 mm dishes and grown for 3 days before
treatment with 250 ng/ml Trail.
For transient transfection, 1.5 · 10
6 cells were seeded into
100 mm cell culture dishes and grown for 24 h before trans-
fection with 4–10 mg pCMV2A or pCDNA3 vector using
Lipofectamine/Plus reagent (Invitrogen). Cells were harvested
at 24–48 h after transfection and the cell lysates were prepared
for further analysis. Transfection with in vitro RNA transcripts
was performed 24 h after transfection with pCMV2A or
pCDNA3 as described below.
In vitro transcription, translation and RNA transfection
In vitro transcription and translation were performed
as described previously (25). Brieﬂy, DNA templates of
pCRLM2 and pCRSM2 were linearized with BamH1, and
the transcripts with 50-cap were synthesized using T7 RNA
polymerase in the presence of 1 mM m
7GpppG and puriﬁed
using the Qiagen RNeasy mini kit. A 20–40 ng of the capped
RNA transcripts were used to program cell-free translation
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containing 3.5 ml of RRL and 3–4 mCi [
35S]methionine. The
products of the translation were separated by SDS–PAGE for
autoradiography analysis.
RNA transfection was performed using the cationic
liposome-mediated method as described previously (25) using
RNA transcripts containing both 50-cap and 30-poly(A) tail.
Brieﬂy, the reporter constructs were linearized with EcoRI and
the transcriptswith 50-cap and 30-poly(A) tail were synthesized
using T7 RNA polymerase in the presence of 1 mM m
7GpppG
and puriﬁed using the Qiagen RNeasy mini kit. Approximately
3 · 10
5 HeLa cells/well were seeded into six-well plates on
the day before transfection. Opti-MEMI medium (1 ml) was
mixed with 12.5 mg of Lipofectin reagent and 5–10 mg RNA
transcripts. The liposome–RNA medium was immediately
added to cells. Control RNA transcripts of b-galactosidase
was co-transfected to monitor transfection efﬁciency. The
cells were harvested at 8 h after the transfection and lysed
for analysis of luciferase activity using the luciferase assay
systems. The activity of b-galactosidase was measured as
described previously (26).
Metabolic labeling
HeLa cells transfected with pCMV2A or vector were trypsin-
ized and re-suspended in serum-free and methionine-free
medium 30 h following transfection. A total of 4 · 10
5 cells/
well were seeded in six-well plate and pulse-labeled for 1 h
with 20 mCi/ml [
35S]methionine. The cells were washed
for three times and precipitated with 10% TCA. The acid-
insoluble material was collected on a ﬁlter by rapid ﬁltration
and the radioactivity was determined by scintillation counting.
For precipitation of pulse-labeled products, the cells were
washed twice with phosphate-buffered saline (PBS) and once
with DMEM lacking methionine followed by incubation
for 2 h in the same medium supplemented with 75 mCi/ml
[
35S]methionine. The pulse-labeled cells were then washed
three times with PBS and harvested for cell lysate preparation
and immunoprecipitation.
Sample preparation, western blot and
immunoprecipitation
Sample preparation, western blot and immunoprecipitation
analyses were performed as described previously (22). Brieﬂy,
cell lysates were prepared by lysis of cells with TNN-SDS
buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 0.5% Non-
idet P-40, 50 mM NaF, 1 mM sodium orthovanadate, 1 mM
DTT, 0.1% SDS and 2 mM phenylmethylsulfonyl ﬂuoride)
at 4 C for 30 min followed by centrifugation (10000 g for
10 min at 4 C) and protein concentration measurement using
Bradford method (27). The cell lysates were separated by 8%
SDS–PAGE and transferred to a PVDF membrane for western
blotanalysiswithactinmonoclonalantibody(1:3000dilution),
M2monoclonalantibodyYL1/2(1:500dilution),andM2poly-
clonalantibodiesantiLM2 (1:1000)andantiSM2(1:1000).For
immunoprecipitation, SDS and DTT were added to cell lysates
of 200–500 mg proteins to ﬁnal concentrations of 0.5% and
10 mM, respectively. The samples were boiled for 15 min,
diluted 10-fold with TNN buffer containing 2% BSA but
without SDS and DTT, and then mixed with 30 ml 50% protein
G-Sepharose 4B slurry. The mixture was incubated at 4 C
for 1 h and centrifuged to remove Sepharose beads together
with non-speciﬁcally bound proteins. To the supernatant,
10 ml of antibody was added and incubated at 4 C for 3 h
before mixing with 30 ml 50% protein G-Sepharose 4B slurry.
The mixture was further incubated overnight at 4 C with
agitation. The precipitate was collected by centrifugation
and washed six times with TNN-SDS buffer. The ﬁnal pellet
was solubilized in 15 ml sample buffer for SDS–PAGE and
autoradiography.
RNA purification and RNase protection assay
The cells were harvested and the total RNA was extracted
using RNeasy Mini Kit (Qiagen). RNase protection assay was
performed as previously described with 10–20 mg total RNAs
(22) by using RPA-III kit (Ambion, Austin, TX) according to
the instructions of the supplier. The constitutively expressed
human GAPDH gene obtained from Ambion (Austin, TX) was
used as a control for RNase protection assay.
Real-time PCR analysis of RNA stability
Ten micrograms in vitro transcripts of reporter constructs
containing 50-cap and 30-poly(A) tail were co-transfected
into HeLa cells with 10 mgo fb-galactosidase transcripts as
described above. Eight hours following transfection, total
RNAs were extracted and the levels of luciferase RNAs and
b-galactosidase RNAs were determined using real-time quant-
itative PCR analysis as described previously (28). Brieﬂy,
2 mg of total RNAs were reverse transcribed using AMV
Reverse Transcriptase and Oligo(dT)12–18 primer (Invitrogen).
The PCRs were carried out in ABI Prism@7000 Sequence
Detection System (Applied Biosystems) using SYBR Green
diction according to the manufacturer’s instructions. The
primers used for reporter luciferase RNAs are 50-GCGAA-
GGTTGTGGATCTGGAT-30 (forward) and 50-CACACAC-
AGTTCGCCTCTTTG-30 (reverse). The primers used for
b-galactosidase RNAs are 50-TGCTGCACGCGGAAGAA-30
(forward) and 50-AGTCGTCGCCACCAATCC-30 (reverse).
The threshold cycle (Ct) was deﬁned as the PCR cycle number
at which the reporter ﬂuorescence crosses the threshold
reﬂecting a statistically signiﬁcant point above the calculated
baseline. The Ct of each target product was determined and
normalized against that of co-transfected b-galactosidase
control. The relative luciferase RNA level = 2DCt.
RESULTS
Effect of the 50-UTR sequence on the translation of
M2 RNA transcripts
It has been reported that the M2 gene possesses two promoters
that are responsible for the production of two major tran-
scripts with 50-UTRs of 63 and 222 nt, respectively (23,24)
(Figure 1A). Northern blot analysis also showed that two
populations of M2 mRNA exist in HeLa cells (Figure 1B),
consistent with the reported ones (23,24). Examining the
sequence of the 222 nt 50-UTR of the known M2 sequence
showed that it has four extra AUG triplets, all in the same
reading frame as the believed physiological translation initi-
ation codon AUG (Figure 1A).
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translation initiation codons to produce a M2 protein with
extended N-terminus, we ﬁrst produced two antibodies against
the predicted N-terminus of the putative long form of M2
(antiLM2) and an internal sequence of the short form of M2
(antiSM2) (see underlined amino acid sequence in Figure 1A).
These antibodies were then used to probe a western blot of
HeLacelllysate.AsshowninFigure1B,onlyM2proteinof43
kDa which is consistent with the product translated from the
presumed physiological initiation site was detected by
the antiSM2 antibody. No bigger protein between the size
of 43 and 49 kDa (corresponding to the size of the longest
form of M2) was detected by this antibody, suggesting that
the longer forms of M2 with an extended N-terminus may
not exist in HeLa cells. The use of antiLM2 antibody also
did not detect any M2 protein of 49 kDa (data not shown),
consistent with the results of antiSM2. These observations are
also consistent with previous reports where no long form of
M2 was found (23,24).
The ﬁnding that HeLa cells express a longer form of M2
mRNA, yet do not express the detectable level of a longer
form of M2 protein, makes it of interest to determine whether
the longer form of M2 mRNA is translationally competent.
For this purpose, we engineered M2-expression constructs,
pCRLM2 and pCRSM2 (Figure 1C), containing the long and
short 50-UTR sequences, respectively, for in vitro translation
analysis. In vitro transcripts with 50-caps were generated from
these constructs using T7 RNA polymerase at similar levels
(Figure 1D) and were then used to program cell-free transla-
tion in RRL. As shown in Figure 1E, the RNA transcripts
containing the short (63 nt) 50-UTR (SM2) directed the abund-
ant production of the expected M2 protein (lanes 3 and 4). The
RNA with the long (222 nt) 50-UTR (LM2) produced a larger
protein, presumably due to the use of a upstream AUG as
a translation initiation codon (lanes 1 and 2). However, the
translation efﬁciency using this upstream codon is extremely
low compared with the physiological AUG codon in the
SM2 construct (Figure 1E, compare lanes 1 and 2 with
lanes 3 and 4). It also appears that the physiological AUG
codon in the longer construct LM2 was not used for translation
initiation in vitro to generate the short form of M2 protein.
We next investigated the effect of the long 50-UTR on
translation of M2 in vivo. For this purpose, both the long and
short 50-UTR sequences of M2 were cloned at the upstream
of the open reading frame (ORF) of luciferase reporter gene,
resulting in constructs pCRL-Luc-A30 and pCRS-Luc-A30
(Figure 2A), respectively. In vitro transcripts with both
50-caps and 50-poly(A) tails were generated at similar levels
Figure 1. In vitro translation of M2 mRNA with different 50-UTRs. (A) The DNA sequence encoding the 50-UTR of M2 mRNA. The upstream AUG codons were
underlined and the physiological start codon was boxed. The transcription start sites for mRNAs with both long and short 50-UTRs were marked with arrows. The
protein sequence encoded by the 50-UTR is also shown with the underlined sequence used for antibody production. (B) Expression of endogenous M2 mRNA and
proteininHeLacells.NorthernandwesternblotanalyseswereconductedtodeterminethemRNAandproteinspecies,respectively.(C)Schematicrepresentationof
expression constructs with two different 50-UTRs of M2 cDNA. T7 promoter and the M2 ORF are boxed. Arrows indicate the transcription start site. (D) RNA
transcripts. The RNAs were generated from linearized M2 expression constructs by in vitro transcription using T7 RNA polymerase. (E) M2 protein generated by
in vitro translation in RRL using the in vitro RNA transcripts as template shown in (D). The products were labeled with [
35S]methionine and detected as described
in Materials and Methods. LM2, M2 with long 50-UTR; SM2, M2 with short 50-UTR.
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merase and were then used to transfect HeLa cells. Eight hours
following transfection with the RNA transcripts, cell lysates
were prepared for luciferase assay. As shown in Figure 2C,
the transcripts with the long 50-UTR of M2 generated negli-
gible luciferase activity, whereas the transcripts with the short
50-UTR of M2 generated abundant luciferase activity. This
observation is consistent with that shown in the in vitro studies
(compare Figure 2C with Figure 1E). Together, the results
from both the in vitro and in vivo analyses suggest that the
long 50-UTR of M2 mRNA inhibits the translation initiation
from the physiological AUG initiation codon and the upstream
in-frame AUGs are poor initiation sites for translation.
The upstream AUG triplets in the long 50-UTR of
M2 mRNA inhibits translation initiation at the
physiological initiation codon
The results in Figures 1 and 2 suggest that not only the
upstream AUGs are poor initiation sites for translation, but
also the long 50-UTRs with these AUGs inhibit translation
initiation at the downstream physiological initiation codon.
We thought that the inhibitory effect of the long 50-UTR on
translationinitiationatthe physiological AUG initiationcodon
is possibly due to its length and/or the secondary structure.
To test this hypothesis and to localize the cis translation regu-
latory elements in the 50-UTR of M2 mRNA, we performed
deletion mapping analysis. The long 50-UTRs of M2 were
deleted at the cDNA level from the 50 end, and the various
truncated 50-UTRs were inserted in front of luciferase reporter,
resulting in a set of deletion mutant constructs (Figure 3A).
In vitro transcripts with 50-caps and 30-poly(A) tails were then
generated from these constructs (Figure 3B) and were intro-
duced into HeLa cells for translation efﬁciency analysis
by measuring luciferase activity. As shown in Figure 3C,
the luciferase expression increased with the 50-deletions and
reached maximum with a deletion of the ﬁrst 100 nt in the
construct LM2D4. The luciferase expression then decreased
with further deletions and reached plateau with deletion
construct of LM2D6, which has a 50-UTR of only 75 nt.
These observations suggest that the long 50-UTR of M2
contains translational regulatory elements and the inhibitory
effect is not simplydue to the length of the 50-UTR. Likely, the
50 region ( 222 to  120) contains an inhibitory element
whereas the middle region ( 120 to  63) contains an enhan-
cer element for translation of the luciferase reporter gene.
Alternatively, the deletion may have changed the secondary
structure of the 50-UTR and, thus, affects the translation
Figure 2. Translation of RNA transcripts with two different 50-UTRs of
M2 mRNA in HeLa cells. (A) Schematic representation of the reporter
constructs containing the M2 50-UTR. T7 promoter and the luciferase reporter
gene are boxed. The poly(A) tail is shown as A30. Arrows indicate the tran-
scription start site. (B) RNA transcripts of luciferase with different M2
50-UTRs. The RNAs were generated from linearized reporter expression
constructs by in vitro transcription using T7 RNA polymerase. (C) Translation
of luciferase reporter with different M2 50-UTRs. The translation efficiency
of luciferase reporter was measured by the determination of the relative
luciferase activity in HeLa cells following transfection of the RNA
transcripts shown in (B) and normalization to the activity of the co-transfected
b-galactosidase.
Figure 3. The long 50-UTR of M2 contains negative cis regulatory elements.
(A) Schematic representation of reporter constructs with wild-type and trun-
cated M2 50-UTRs. The solid and open boxes indicate the upstream AUGs and
luciferase genes, respectively. A30 represents the poly(A) tail of the in vitro
RNAtranscriptsgeneratedfromtheseconstructs.Thefreeenergyofthe50-UTR
in each construct was predicated using the mfold 3.1 algorithm (http://
www.bioinfo.rpi.edu/~zukerm/rna/). (B) RNA transcripts of luciferase with
different M2 50-UTRs. The RNAs were generated from linearized reporter
expression constructs by in vitro transcription using T7 RNA polymerase.
(C) Translation of luciferase reporter with different M2 50-UTRs. The transla-
tion of luciferase reporter was measured by the determination of the relative
luciferase activity in HeLa cells following transfection of the RNA transcripts
shown in (B) and normalization to the activity of the co-transfected b-galacto-
sidase. (D) Real-time PCR analysis of RNA levels of luciferase reporter with
different M2 50-UTRs. In vitro transcripts of luciferase reporters with different
M2 50-UTRs were co-transfected into HeLa cells with transcripts of b-galac-
tosidase.TotalRNAswerethenisolated8hfollowingtransfectionforreal-time
PCR analysis and the relative levels of luciferase RNAs were determined as
described in Materials and Methods.
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of the deletion mutants showed that the free energy of these
constructs decreased with the deletion (Figure 3A), which
suggests that with the decreased complexity in secondary
structure the translation efﬁciency should increase. Yet, we
observed initially an increase and later a decrease in trans-
lation efﬁciency. Hence, it is unlikely that the change in
translation efﬁciency is due to the simple change in secondary
structures of the 50-UTR sequence.
To rule out the possibility that the effect of deletion of the
50-UTRs on the luciferase activity is due to their effect on the
stability of these transcripts, we conducted an experiment
to quantify the remaining transcripts of all constructs in the
cells 8 h following transfection. As shown in Figure 3D, the
remaining quantity of all transcripts with deletion appears to
be similar to that of the wild-type sequence (LM2). Hence,
it is unlikely that the deletion of the 50-UTR changed the
stability of the transcripts which then affected the luciferase
activity level.
However, it is interesting to note that the inhibitory element
inthe 50 region( 222to 120)possesses allthe four upstream
AUG triplets. It is possible that these AUG triplets function as
cis elements to inhibit translation initiation at the downstream
physiological AUG initiation codon. To test this possibility,
we engineered reporter constructs with point mutations to
eliminate the AUG codons by mutating the AUGs to UUCs
while maintaining the length of the 50-UTRs (Figure 4A).
Again, in vitro transcripts with 50-caps and 30-poly(A) tails
weregeneratedfromtheseconstructs(Figure 4B)andthesame
amount of RNA transcripts were introduced into HeLa cells
for translation efﬁciency analysis by measuring the luciferase
activity. As shown in Figure 4C, the luciferase expression
increased with the mutation of the upstream AUG triplets
and reached maximum (similar to the shorter 50-UTR, SM2)
with the mutation of all four upstream AUG triplets (LM2U4).
Hence, the upstream AUG triplets in the 50-UTR sequence
of M2 mRNA likely act as inhibitors of the translation
initiation at the physiological initiation codon of the long
M2 mRNA. Interestingly, all AUG mutant RNA transcripts
have similar complexity of secondary structures at their
50-UTRs (Figure 4A, similar DG) and, yet, their translation
efﬁciencies are very different, supporting our argument that
the secondary structure at the 50-UTR and its length is not
responsible for the inhibition of the translation efﬁciency.
We also tested the stability of the transcripts with mutated
AUGs using real-time PCR as described above. As shown
in Figure 4D, the remaining quantity of all transcripts with
point mutations appears to be similar to that of the wild-type
sequence (LM2) 8 h following transfection. Hence, the
point mutations of upstream AUGs did not change the stability
of the transcripts which then affected the luciferase activity
level.
The inhibition of translation by upstream
AUG triplets requires intact eIF4G
It has been reported that AUG triplets in the 50-UTR of
mRNAs could act as translation regulator by inhibiting the
cap-dependent translation at the physiological AUG initiation
codon (29). It has also been shown previously that poliovirus
2A
pro cleaves both forms of translation initiation factor eIF4G,
causing extensive inhibition of cap-dependent mRNA trans-
lation (30,31). To determine whether the upstream AUG
triplets in the long 50-UTR sequence of the M2 mRNA may
inhibit the cap-dependent translation initiation at the physio-
logical AUG codon, we analyzed the expression proﬁle of
various reporter constructs following inhibition of cap-
dependent translation by transiently expressing poliovirus
2A
pro in HeLa cells. A mammalian expression vector that
carries the poliovirus 2A
pro gene was transiently transfected
into HeLa cells, and the global protein synthesis was mon-
itored by measuring [
35S]methionine incorporation. As shown
in Figure 5A, the [
35S]methionine incorporation decreased
about half by expressing poliovirus 2A
pro, suggesting that
the global protein synthesis was inhibited by 2A
pro cleavage
Figure 4. The upstream AUG triplets act as negative cis regulatory elements.
(A).Schematicrepresentationofreporterconstructswithwild-typeandmutant
M2 50-UTRs. The solid and open boxes indicate the upstream AUGs and
luciferase genes, respectively. A30 represents the poly(A) tail of the in vitro
RNAtranscriptsgeneratedfromtheseconstructs.Thefreeenergyofthe50-UTR
in each construct was predicated using the mfold 3.1 algorithm (http://www.
bioinfo.rpi.edu/~zukerm/rna/). In the mutants, the upstream AUGs were
mutated to UUCs. (B) RNA transcripts of luciferase with different M2
50-UTRs. The RNAs were generated from linearized reporter expression
constructs by in vitro transcription using T7 RNA polymerase. (C) Translation
of luciferase reporter with different M2 50-UTRs. The translation of luciferase
reporterwasmeasuredbythedeterminationoftherelativeluciferaseactivityin
HeLa cells following transfection of the RNA transcripts shown in (B) and
normalization to the activity of the co-transfected b-galactosidase. (D)
Real-time PCR analysis of RNA levels of luciferase reporter with different
M2 50-UTRs. In vitro transcripts of luciferase reporters with different M2
50-UTRswereco-transfectedintoHeLacellswithtranscriptsofb-galactosidase
andthenreal-timePCRanalysiswasperformedasdescribedinFigure3legend.
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virus 2A
pro on the translation efﬁciency of the RNA transcripts
with or without the upstream AUG triplets in the 50-UTR of
M2. As shown in Figure 5B and C, the expression of 2A
pro
increased the translation of luciferase reporter with the long
M2 50-UTR (LM2) by 20- to 30-fold, whereas the translation
of the luciferase with the short M2 50-UTR (SM2) was not
affectedsigniﬁcantly.Theeffect ofthe 2A
pro expression onthe
translation of luciferase reporter with various AUG mutants
of M2 50-UTRs decreased with the increase in the number
of AUG triplets removed either by deletion (Figure 5B) or
by site-speciﬁc mutations (Figure 5C). We next determined
whether the expression 2A
pro affects the RNA stability of
luciferase reporter transcripts with different M2 50-UTRs
using real-time PCR as described above in Figures 3D and
4D. As shown in Figure 6, the remaining quantity of all RNA
transcripts did not change signiﬁcantly 8 h following transfec-
tionbothinthepresenceofthe controlvector(Figure6AandC)
and the 2A
pro expression plasmid (Figure 6B and D). These
results suggest that the inhibitory effect of upstream AUG
triplets on translation initiation at the physiological AUG
were released by 2A
pro expression and, thus, the inhibitory
effects likely require intact eIF4G.
2A
pro in HeLa cells increased the expression level of
endogenous M2
Based on the above observation that expressing 2A
pro
increased the translation of transcripts with long 50-UTRs but
had little effect on the translation of transcripts with short
50-UTRs of M2, we thought that the endogenous M2 protein
level should increase due to the activated translation from
the M2 mRNA with long 50-UTRs by expressing poliovirus
2A
pro. To test this possibility, we transfected HeLa cells with
2A
pro and determined the endogenous M2 level. As shown in
Figure 7A, the protein level of M2 was increased following
2A
pro transfection as determined by western blot. It is note-
worthy that the level of b-actin was decreased  50% follow-
ing 2A
pro transfection, consistent with the observation that
2A
pro decreased the global protein synthesis (Figure 5A).
However, the total mRNA level of M2 was not changed signi-
ﬁcantly as determined by RNase protection assay (Figure 7B).
To determine whether the increase in endogenous M2 protein
was due to the increased protein synthesis, a pulse-labeling
by [
35S]methionine followed by immunoprecipitation was
performed following 2A
pro transfection. As shown in
Figure 7C, the newly synthesized M2 protein was indeed
increased drastically following 2A
pro transfection. Hence, the
increased level of endogenous M2 protein following 2A
pro
transfection is likely due to the increased synthesis rate of
M2 protein and it may be by activating the translation of
M2 transcripts with the long 50-UTRs.
Trail treatment increased the expression level of
endogenous M2
Because poliovirus 2A
pro cleaves eIF4G and, thus, inhibits
cap-dependent translation, it is possible that the increase in
endogenous M2 protein synthesis following 2A
pro transfection
was due to the decreased inhibition of translation of M2
mRNA with long 50-UTRs. To conﬁrm that the eIF4G is
involved, we took another approach by treating cells with
Trail. It has been reported that treating HeLa cells with
Trail for 4 h would cause cleavage of eIF4G, thus, impair
the cap-dependent translation initiation and decrease the
incorporation of [
35S]methionine (32). To test the effect of
Trail on the expression of M2, we treated HeLa cellswith Trail
for 4 h and then detected the protein level of M2 using western
blot. As shown in Figure 8A, the endogenous M2 protein level
was increased following treatment with Trail. However, the
M2 mRNA level was not changed signiﬁcantly as deter-
mined by RNase protection assay (Figure 8B). The result of
pulse-labeling by [
35S]methionine and immunoprecipitation
following Trail treatment showed that the synthesis rate of
M2 protein was increased (Figure 8C). Hence, the increase
in the level of endogenous M2 protein following Trail treat-
ment is likely due to the increased synthesis rate of M2 protein
and it may be by activating the translation of M2 transcripts
with long 50-UTRs.This result is consistent with that shownby
transiently expressing 2A
pro in HeLa cells (Figure 7).
Figure5.Effectofpoliovirusprotease2AonthetranslationofluciferasereportertranscriptswithdifferentM250-UTRs.(A)Effectofpoliovirusprotease2A(2A
pro)
on global translation. The effect of 2A
pro on global protein synthesis was determined by measuring total incorporation of [
35S]methionine following transfection of
HeLacellswith2A
proasdescribedinMaterialsandMethods.(B)Effectofpoliovirus2A
proonthetranslationofluciferasereporterwithwild-typeandtruncatedM2
50-UTRs. The translation of luciferase reporter was measured by the determination of the luciferase activity in HeLa cells by first transfecting the cells with 2A
pro
followedbytransfectionwiththeRNAtranscriptscontainingthewild-typeandtruncatedM250-UTRsasdescribedinMaterialsandMethods.Therelativeluciferase
activitywascalculatedbynormalizingtotheactivityoftheco-transfectedb-galactosidase.(C)Effectofpoliovirus2A
proontranslationofluciferasereporterwithM2
50-UTRs containing mutated AUG triplets. The translation of luciferase reporter was measured as described in (B).
Nucleic Acids Research, 2005, Vol. 33, No. 8 2721Figure 7. Effect of poliovirus protease 2A on the expression of endogenous
M2.(A)Effectof2A
proonthelevelofendogenousM2protein.Theexpression
level of endogenous M2 protein in HeLa cells was determined using western
blot at 24 and 36 h following transfection of the cells with 2A
pro.( B) Effect of
2A
pro on the endogenous M2 mRNA. The expression level of endogenous M2
mRNAinHeLacellswasdetectedusingRNaseprotectionassay36hfollowing
transfection of the cells with 2A
pro.( C) Effect of 2A
pro on the synthesis of
endogenousM2protein.HeLacellswerefirsttransfectedwith2A
proorcontrol
vector followed by pulse labeling of newly synthesized proteins with
[
35S]methionine. M2 protein was then immunoprecipitated and separated by
SDS–PAGE for autoradiography as described in Materials and Methods.
Figure 6. Effect of poliovirus protease 2A on stability of luciferase reporter transcripts with different M2 50-UTRs. In vitro transcripts of luciferase reporters with
differentM250-UTRscarryingdeletions(AandB)orpointmutations(CandD)wereco-transfectedintoHeLacellswithtranscriptsofb-galactosidase24hfollowing
transfection with pcDNA3 (A and C) or 2A
pro expression plasmid (B and C). Total RNAs were then isolated 8 h following RNA transfection for real-time PCR
analysis and the relative levels of luciferase RNAs were determined as described in Materials and Methods.
Figure 8. Effect of Trail on the expression of endogenous M2. (A) Effect
of Trail on the level of endogenous M2 protein. The expression level of
endogenous M2 protein in HeLa cells was determined using western blot 4 h
following Trail (250 mg/ml) treatment. (B) Effect of Trail on the endogenous
M2 mRNA. The expression level of endogenous M2 mRNA in HeLa cells was
detected using RNase protection assay 4 h following Trail (250 mg/ml) treat-
ment.(C)EffectofTrailonthesynthesisofendogenousM2protein.HeLacells
were first treated with 250 mg/ml Trail followed by pulse labeling of newly
synthesized proteins with [
35S]methionine. M2 protein was then immunopre-
cipitated and separated by SDS–PAGE for autoradiography as described in
Materials and Methods.
2722 Nucleic Acids Research, 2005, Vol. 33, No. 8DISCUSSION
Post-transcriptional controls including translational regulation
are major regulatory steps for gene expression. Alteration in
the expression level of translation initiation factors may cause
tumorigenesis or increase the malignancy of cancer cells
(21,33–36). Increasing evidence suggests that both the 50-
and the 30-UTRs of mRNAs are major cis regulatory elements
for the translational control of mRNAs.
Ineukaryotes,thetranslationinitiationusesacap-dependent
scanning mechanism (37,38), with which the 50-cap structure
of mRNAs is ﬁrst recognized by cap-binding factor eIF4E
followed by binding of the 40S ribosome and scanning down-
stream of the 50-UTR to the initiation codon. However, the
existence of upstream AUG codons or ORFs in the 50-UTRs
will likely affect the translation initiation at the physiological
initiation codon if the scanning mechanism is to be used and
they may play an important role as cis elements regulating the
translation of the mRNA [reviewed in (39,40)].
Mammalian RR M2 has two mRNAs with different
50-UTRs generated by transcription at two different start sites
(23,24). In order to investigate the translation regulation of
these two kinds of mRNA, we employed both in vitro trans-
lation and RNA transfection (in vivo) techniques. The advant-
age of using the RNA transfection technique to study the
translation regulation is to avoid the inﬂuence of unknown
factors in the transcription procedure if DNA plasmids were
to be used. We found that while the mRNA with a short
50-UTR (63 nt) can be translated efﬁciently likely using the
ribosomescanning mechanism,themRNAwithalong50-UTR
(222 nt) cannot be translated efﬁciently either in vitro or
in vivo. Although the long 50-UTR has four AUG triplets,
which are all in frame with the physiological AUG initiation
codon, they are not used efﬁciently for translation to generate
a protein with an extended N-terminus. Hence, these AUG
triplets in the long 50-UTR are not functional as translation
initiation codons to generate M2 in vivo. However, we found
instead that these AUG triplets act as translation regulators to
control the translation of the M2 mRNA with the long 50-UTR
sequence. These AUG triplets inhibit the efﬁcient translation
initiation at the physiological AUG initiation codon and this
inhibition appears to be dependent on the presence of intact
cellular eIF4G. We also ruled out the possibility that the
stability of luciferase reporter transcripts with different M2
50-UTRs is different, which could affect the ﬁnal expression
level of luciferase activity by performing real-time PCR
analysis (Figures 3D and 4D).
Under various conditions, such as during viral infection and
apoptosis, the cap-dependent translation initiation is inhibited
due to the cleavage of eIF4G by proteases. eIF4G serves as a
scaffold molecule bridging eIF4E (the 50-cap binding protein)
and eIF4A (the RNA helicase) and help recruit eIF3, poly(A)-
binding protein, and 40S ribosome complex for the formation
of preinitiation complexes. With the cleavage of eIF4G by
2A
pro during viral infection (30,31) or by caspases during
apoptosis (32), the recruitment of ribosomes and eIF3 to the
50 end of mRNAs cannot be accomplished and, thus, the cap-
dependent translation will be inhibited. The ﬁnding that
expressing 2A
pro drastically reduced the inhibitory effect of
the upstream AUGs on the translation from the physiological
start codon AUG of M2 suggests that this inhibition requires
intact eIF4G and it is likely by the cap-dependent translation
initiation mechanism.
The regulation by the upstream AUGs or ORFs has been
observed for other eukaryotic mRNAs (39,40). It has been
thought that the small peptide encoded by the upstream
ORF may be involved in regulation. While the mechanism
of translational regulation by the upstream AUGs or ORFs
varies with different transcripts, most of these AUGs or
ORFs are inhibitory for the translation initiation at the physio-
logical start codon. However, the upstream ORFs in yeast
GCN4 (41) and mouse ATF4 (42) are known to be stimulatory
under stressed conditions. Because the upstream AUGs in the
M2 transcript are in the same reading frame as the physio-
logical start codon and no additional stop codons exist in
this frame, no separate small peptides are encoded by these
upstream sequences. Only a protein with an extended
N-terminus was produced by initiating at the upstream AUG
in vitro as shown in Figure 1. Hence, it is unlikely that the
translational regulatory effect of these AUG triplets in the M2
transcripts is due to the production of a small peptide or by
reinitiation (39). Considering that the inhibitory effect is
cap-dependent, it is more likely that the translation elongation
initiated at any of the upstream AUGs by the cap-dependent
mechanism may be stalled by the existence of potential com-
plex secondary structures in the 50-UTR sequence of the long
M2 transcript (40). Hence, no M2 protein with extended
N-terminus can be produced.
Analysis of the sequence between the upstream AUGs
and the physiological initiation codon AUG using an online
software (http://www.bioinfo.rpi.edu/~zukerm/rna/) showed
that there is a stable secondary stem–loop structure of
 52.5 kcal/mol (Figure 9A and B). This structure likely serves
as a barrier for the moving of ribosomes during elongation
after initiation at one of the upstream AUGs (Figure 9C).
When the upstream AUGs are removed by deletion or muta-
tion, the preinitiation complex formed at the 50 end of
the mRNA may be able to scan through the 50-UTR for the
physiological AUG initiation codon while the eIF4A in the
complex help unwind the secondary stem–loop structures of
the 50-UTR sequence. This unwinding process cannot be
accomplished during translation elongation if the upstream
AUGs are used for initiation because eIF4A are released
together with other factors following the initiation at these
upstream AUGs (43). This hypothesis is in contradiction to
the conclusion from in vitro studies, which showed that the
elongating 80S ribosome has more melting power than the 40S
ribosome (43). In the Kozak study (43), an AUG initiation
codon engineered upstream of a  61 kcal/mol hairpin resulted
in the production of CAT reporter, whereas the transcript
lacking the upstream AUG could not be translated. However,
completely opposite observation was made with the M2 tran-
script in this study where transcripts with upstream AUGs
could not be translated and removal of these AUGs drastically
enhanced the translation of the transcript. The reason for the
difference between these studies is currently unknown.
Further close examination of the 50-UTR sequence showed
that three of the four upstream AUGs share completely ident-
ical ﬂanking sequences (Figure 9D). It is, thus, also possible
that these consensus sequences in the 50-UTR causes instab-
ility of the mRNA with these 50-UTRs and, thus, the produc-
tion of proteins from these mRNAs are drastically reduced.
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that the 50-UTR of mouse M2 contains a sequence that can
bind to a cytosolic protein to destabilize the mRNA (44,45).
It is thus possible that these consensus sequences may bind
a destabilizing factor that causes degradation of the mRNA.
However, this possibility is unlikely as we have clearly shown
that the stability of transcripts with altered upstream AUGs did
not increase (Figures 3D and 4D).
It is still also possible that these consensus sequences
may bind to a protein factor, which blocks the movement
of ribosomes during scanning process (Figure 9E). Under
stressed conditions such as during viral infection or apoptosis
when eIF4G is cleaved and the cap-dependent translation is
inhibited, another mechanism such as cap-independent initi-
ation (such as the putative IRES-mediated initiation) may be
used. It is tempting to speculate that, under these conditions,
theproteinsboundtotheseconsensussitesmayalsobecleaved
similarly as eIF4G and, thus, these sites become exposed for
recruiting factors required for cap-independent initiations of
translation at the physiological AUG start codon of the M2
mRNA with a long 50-UTR. We are currently testing this
possibility.
The ﬁnding that the translation of the M2 mRNAs with a
long50-UTR ishighlyregulatedisveryimportant.Duringviral
infections when the translation of cellular mRNAs are stopped
due to hijacking of the translational machinery by virus for its
own use, some cellular mRNAs still need to be translated for
the viral replication. RR is one of the enzymes that would be
required to make deoxyribonucleotides for replication of the
viral genome. Activated translation from the M2 mRNA with
the long 50-UTR under such conditions will help provide suf-
ﬁcient enzymes for the increased requirement by virus. In this
study, we indeed found that the endogenous M2 was increased
by expressing 2A
pro or by treating cells with Trail and this
increase was due to the elevated synthesis of M2 protein
(Figures 7 and 8). We speculate that this increase in M2 syn-
thesis is likely due to the activated translation of the mRNA
with a long 50-UTR because the translation of the mRNA with
a short 50-UTR is not affected by 2A
pro (Figure 5). In addition,
during the S phase of cell cycle more RRs are needed and M2
has been shown to increase. Translation of the M2 mRNA with
long 50-UTRs may also be activated during S phases for DNA
synthesis.
ACKNOWLEDGEMENTS
The authors would like to thank Dr Robert G. Korneluk
(Apoptogen Inc, Ottawa, Canada) for the 2A
pro expression
plasmid. This work was supported in part by grants from the
National Institutes of Health (CA64539 and CA94961) and
Department of Defense (DAMD170010297). Z.D was sup-
ported, in part, by the NRSA T32 DK07519 from the
National Institutes of Health. Funding to pay the Open
Access publication charges for this article was provided
by National Institutes of Health.
Conflict of interest statement. None declared.
REFERENCES
1. Wright,J.A., Chan,A.K., Choy,B.K., Hurta,R.A., McClarty,G.A. and
Tagger,A.Y. (1990) Regulation and drug resistance mechanisms
of mammalian ribonucleotide reductase, and the significance to DNA
synthesis. Biochem. Cell Biol., 68, 1364–1371.
2. Thelander,L. and Reichard,P. (1979) Reduction of ribonucleotides.
Annu. Rev. Biochem., 48, 133–158.
3. Reichard,P. (1988) Interactions between deoxyribonucleotide and DNA
synthesis. Annu. Rev. Biochem., 57, 349–374.
4. Engstrom,Y., Eriksson,S., Jildevik,I., Skog,S., Thelander,L. and
Tribukait,B. (1985) Cell cycle-dependent expression of mammalian
Figure 9. Model for translational regulation of M2 mRNA with the long
50-UTR. (A) Secondary structure of 50-UTR sequence between  120 and the
physiologicalstartcodonAUG.Thesecondarystructurewaspredictedusingan
online program (http://www.bioinfo.rpi.edu/~zukerm/rna/). (B) Schematic
representation of the secondary structure (hairpin) relative to the upstream
and the physiological start AUGs (filled boxes) in the long 50-UTR of M2
mRNA. (C) Model of inhibition of translation initiation at the physiological
start codon. The secondary structure severs as a barrier for the moving of
ribosomes during elongation with initiation at one of the upstream AUGs.
(D) Alignment of the AUG triplets with their flanking sequences. The con-
sensus Kozak sequence is also shown. (E) Model of protein-bound upstream
AUG triplets.Anhypothetical protein(filledcircle)bindsto anupstreamAUG
triplet with conserved flanking sequences, which blocks the movement of
ribosomes during the elongation of translation initiated at an upstream AUG.
2724 Nucleic Acids Research, 2005, Vol. 33, No. 8ribonucleotide reductase. Differential regulation of the two subunits.
J. Biol. Chem., 260, 9114–9116.
5. Mann,G.J., Musgrove,E.A., Fox,R.M. and Thelander,L. (1988)
Ribonucleotide reductase M1 subunit in cellular proliferation,
quiescence, and differentiation. Cancer Res., 48, 5151–5156.
6. Eriksson,S.,Graslund,A.,Skog,S.,Thelander,L.andTribukait,B.(1984)
Cell cycle-dependent regulation of mammalian ribonucleotide
reductase. The S phase-correlated increase in subunit M2 is regulated
by de novo protein synthesis. J. Biol. Chem., 259, 11695–11700.
7. Bjorklund,S., Skog,S., Tribukait,B. and Thelander,L. (1990)
S-phase-specific expression of mammalian ribonucleotide reductase
R1 and R2 subunit mRNAs. Biochemistry, 29, 5452–5458.
8. Fan,H.,Villegas,C.andWright,J.A.(1996)RibonucleotidereductaseR2
component is a novel malignancy determinant that cooperates with
activated oncogenes to determine transformation and malignant
potential. Proc. Natl Acad. Sci. USA, 93, 14036–14040.
9. Zhou,B.S., Tsai,P., Ker,R., Tsai,J., Ho,R., Yu,J., Shih,J. and Yen,Y.
(1998) Overexpression of transfected human ribonucleotide reductase
M2 subunit in human cancer cells enhances their invasive potential.
Clin. Exp. Metastasis, 16, 43–49.
10. Zhou,B.S., Hsu,N.Y., Pan,B.C., Doroshow,J.H. and Yen,Y. (1995)
Overexpression of ribonucleotide reductase in transfected human KB
cellsincreasestheirresistancetohydroxyurea:M2butnotM1issufficient
to increase resistance to hydroxyurea in transfected cells. Cancer Res.,
55, 1328–1333.
11. Yarbro,J.W.(1992)Mechanismofactionofhydroxyurea.Semin.Oncol.,
19, 1–10.
12. Li,Q., Kasten-Jolly,J., Yen,Y. and Freed,B.M. (1998) Reversal of
hydroquinone-mediated suppression of T cell proliferation by
transfection of the M2 subunit of ribonucleotide reductase.
Toxicol. Appl. Pharmacol., 150, 154–157.
13. Manjeshwar,S., Rao,P.M., Rajalakshmi,S. and Sarma,D.S. (1999)
The regulation of ribonucleoside diphosphate reductase by the tumor
promoter orotic acid in normal rat liver in vivo. Mol. Carcinog.,
24, 188–196.
14. Chen,S., Zhou,B., He,F. and Yen,Y. (2000) Inhibition of human
cancer cell growth by inducible expression of human ribonucleotide
reductase antisense cDNA. Antisense Nucleic Acid Drug Dev.,
10, 111–116.
15. Lee,Y., Vassilakos,A., Feng,N., Lam,V., Xie,H., Wang,M., Jin,H.,
Xiong,K., Liu,C., Wright,J. et al. (2003) GTI-2040, an antisense agent
targeting the small subunit component (R2) of human ribonucleotide
reductase, shows potent antitumor activity against a variety of tumors.
Cancer Res., 63, 2802–2811.
16. Thompson,D.P.,Carter,G.L.andCory,J.G.(1989)Changesinmessenger
RNA levels for the subunits of ribonucleotide reductase during the
cell cycle of leukemia L1210 cells. Cancer Commun., 1, 253–260.
17. Albert,D.A., Nodzenski,E., Yim,G. and Kowalski,J. (1990) Effect of
cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2
subunit messenger RNA concentrations in wild-type and mutant S49
T lymphoma cells. J. Cell. Physiol., 143, 251–256.
18. Feder,J.N., Guidos,C.J., Kusler,B., Carswell,C., Lewis,D. and
Schimke,R.T. (1990) A cell cycle analysis of growth-related genes
expressed during T lymphocyte maturation. J. Cell Biol., 111,
2693–2701.
19. Filatov,D., Bjorklund,S., Johansson,E. and Thelander,L. (1996)
Induction of the mouse ribonucleotide reductase R1 and R2 genes in
responsetoDNAdamagebyUVlight.J.Biol.Chem.,271,23698–23704.
20. Kuo,M.L. and Kinsella,T.J. (1998) Expression of ribonucleotide
reductase after ionizing radiation in human cervical carcinoma cells.
Cancer Res., 58, 2245–2252.
21. Dong,Z., Liu,L.H., Han,B., Pincheira,R. and Zhang,J.T. (2004) Role of
eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and
cell growth. Oncogene, 23, 3790–3801.
22. Dong,Z.andZhang,J.T.(2003)EIF3p170,amediatorofMimosineeffect
on protein synthesis and cell cycle progression. Mol. Biol. Cell, 14,
3942–3951.
23. Park,J.B. and Levine,M. (2000) Characterization of the promoter of the
human ribonucleotide reductase R2 gene. Biochem. Biophys. Res.
Commun., 267, 651–657.
24. Zhou,B.andYen,Y.(2001)Characterizationofthehumanribonucleotide
reductase M2 subunit gene; genomic structure and promoter analyses.
Cytogenet. Cell Genet., 95, 52–59.
25. Han,B. and Zhang,J.T. (2002) Regulation of gene expression by internal
ribosome entry sites or cryptic promoters: the eIF4G story. Mol. Cell.
Biol., 22, 7372–7384.
26. Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular
Cloning,ColdSpringHarborLaboratoryPress,ColdSpringHarbor,NY.
27. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation
of microgram quantities of protein utilizing the principle of protein–dye
binding. Anal. Biochem., 72, 248–254.
28. Liu,Y., Chen,Q. and Zhang,J.T. (2004) Tumor suppressor gene
14-3-3sigma is down-regulated whereas the proto-oncogene translation
elongation factor1deltais up-regulated in non-smallcell lung cancersas
identified by proteomic profiling. J. Proteome Res., 3, 728–735.
29. Fernandez,J., Yaman,I., Merrick,W.C., Koromilas,A., Wek,R.C.,
Sood,R., Hensold,J. and Hatzoglou,M. (2002) Regulation of internal
ribosome entry site-mediated translation by eukaryotic initiation
factor-2alpha phosphorylation and translation of a small upstream open
reading frame. J. Biol. Chem, 277, 2050–2058.
30. Etchison,D., Milburn,S., Edery,I., Sonenberg,N. and Hershey,J. (1982)
Inhibition of HeLa cell protein synthesis following poliovirus
infection correlates with the proteolysis of a 220,000-dalton polypeptide
associated with eucaryotic initiation factor 3 and a cap binding
protein complex. J. Biol. Chem., 257, 14806–14810.
31. Barco,A., Feduchi,E. and Carrasco,L. (2000) A stable HeLa cell line
that inducibly expresses poliovirus 2Apro: effects on cellular and viral
gene expression. J. Virol., 74, 2383–2392.
32. Stoneley,M., Chappell,S.A., Jopling,C.L., Dickens,M., MacFarlane,M.
and Willis,A.E. (2000) c-Myc protein synthesis is initiated from the
internal ribosome entry segment during apoptosis. Mol. Cell. Biol.,
20, 1162–1169.
33. Lazaris-Karatzas,A., Montine,K.S. and Sonenberg,N. (1990) Malignant
transformation by a eukaryotic initiation factor subunit that binds to
mRNA 50 cap. Nature, 345, 544–547.
34. Fukuchi-Shimogori,T., Ishii,I., Kashiwagi,K., Mashiba,H., Ekimoto,H.
and Igarashi,K. (1997) Malignant transformation by overproduction of
translation initiation factor eIF4G. Cancer Res., 57, 5041–5044.
35. Mayeur,G.L. and Hershey,J.W. (2002) Malignant transformation by
the eukaryotic translation initiation factor 3 subunit p48 (eIF3e).
FEBS Lett., 514, 49–54.
36. Donze,O., Jagus,R., Koromilas,A.E., Hershey,J.W. and Sonenberg,N.
(1995) Abrogation of translation initiation factor eIF-2 phosphorylation
causes malignant transformation of NIH 3T3 cells. EMBO J., 14,
3828–3834.
37. Kozak,M.andShatkin,A.J.(1978)Identificationoffeaturesin50 terminal
fragments from reovirus mRNA which are important for ribosome
binding. Cell, 13, 201–212.
38. Kozak,M. (1991) Structural features in eukaryotic mRNAs that
modulate the initiation of translation. J. Biol. Chem., 266,
19867–19870.
39. Geballe,A.P. and Sachs,M.S. (2000) Chapter 18. In Sonenberg,N.,
Hershey,J.W.B.andMethews,M.B.(eds),TranslationalControlofGene
Expression. Cold Spring Harbor Laboratory Press, Cold Spring Harbor,
NY, pp. 595–614.
40. Meijer,H.A. and Thomas,A.A. (2002) Control of eukaryotic protein
synthesis by upstream open reading frames in the 50-untranslated region
of an mRNA. Biochem. J., 367, 1–11.
41. Hinnebusch,A.G. (1995) Chapter 7. In Hershey,J.W.B., Mathews,M.B.
and Sonenberg,N. (eds), Translational Control. Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY, pp. 199–244.
42. Harding,H.P., Novoa,I., Zhang,Y., Zeng,H., Wek,R., Schapira,M. and
Ron,D. (2000) Regulated translation initiation controls stress-induced
gene expression in mammalian cells. Mol. Cell, 6, 1099–1108.
43. Hershey,J.W.B. and Merrick,W.C. (2000) Chapter 2. In Sonenberg,N.,
Hershey,J.W.B. and Mathews,M.B. (eds), Translational Control of
Gene Expression. Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, New York, pp. 33–88.
44. Amara,F.M.,Chen,F.Y.andWright,J.A.(1994)Phorbolestermodulation
of a novel cytoplasmic protein binding activity at the 30-untranslated
region of mammalian ribonucleotide reductase R2 mRNA and role in
message stability. J. Biol. Chem., 269, 6709–6715.
45. Amara,F.M.,Sun,J.andWright,J.A.(1996)Defininganovelcis-element
in the 30-untranslated region of mammalian ribonucleotide reductase
component R2 mRNA. cis–trans-interactions and message stability.
J. Biol. Chem., 271, 20126–20131.
Nucleic Acids Research, 2005, Vol. 33, No. 8 2725